EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders
Cristina Nanni, Christophe M. Deroose, Soňa Balogová, Constantin Lapa, Nadia Withofs, Manil Subesinghe, Bastien Jamet, Elena Zamagni, Davide Ippolito, Michel Delforge, Françoise Kraeber‐Bodéré
Abstract
Abstract We provide updated guidance and standards for the indication, acquisition, and interpretation of [ 18 F]FDG PET/CT for plasma cell disorders. Procedures and characteristics are reported and different scenarios for the clinical use of [ 18 F]FDG PET/CT are discussed. This document provides clinicians and technicians with the best available evidence to support the implementation of [ 18 F]FDG PET/CT imaging in routine practice and future research.
Topics & Concepts
MedicineMedical physicsPositron emission tomographyNuclear medicineRadiologyMultiple Myeloma Research and TreatmentsLymphoma Diagnosis and TreatmentMyeloproliferative Neoplasms: Diagnosis and Treatment